Stent-assisted coiling of large common femoral artery pseudoaneurysm following coronary artery catheterization: an uncommon and novel approach

1. HAMRAOUI K., ERNST SM., VAN DESSEL PF., KELDER JC., TEN BERG JM., SUTTORP MJ., et al. Efficacy and safety of percutaneous treatment of iatrogenic femoral artery pseudoaneurysm by biodegradable collagen injection. J Am Coll Cardiol. 2002; 39(8):1297-304.10.1016/S0735-1097(02)01752-7Search in Google Scholar

2. AHMAD F., TURNER SA., TORRIE P., GIBSON M. Iatrogenic femoral artery pseudoaneurysms--a review of current methods of diagnosis and treatment. Clin Radiol. 2008; 63(12):1310-6.10.1016/j.crad.2008.07.001Search in Google Scholar

3. LENNOX A., GRIFFIN M., NICOLAIDES A., MANSFIELD A. Regarding “Percutaneous ultrasound guided thrombin injection: A new method for treating postcatheterization femoral pseudoaneurysms”. Journal of Vascular Surgery. 28(6):1120-21.10.1016/S0741-5214(98)70041-2Search in Google Scholar

4. O’SULLIVAN GJ., RAY SA., LEWIS JS., LOPEZ AJ., POWELL BW., MOSS AH., et al. A review of alternative approaches in the management of iatrogenic femoral pseudoaneurysms. Ann R Coll Surg Engl. 1999; 81(4):226-34.Search in Google Scholar

5. REEDER SB., WIDLUS DM., LAZINGER M. Low-dose thrombin injection to treat iatrogenic femoral artery pseudoaneurysms. AJR Am J Roentgenol. 2001; 177(3):595-8.10.2214/ajr.177.3.1770595Search in Google Scholar

6. TULSYAN N., KASHYAP VS., GREENBERG RK., SARAC TP., CLAIR DG., PIERCE G., et al. The endovascular management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg. 2007; 45(2):276-83; discussion 83.10.1016/j.jvs.2006.10.049Search in Google Scholar

• A Practical Review of Diabetes Mellitus Type 2 Treatment in Primary Care

• Lupus-related protein-losing enteropathy associated with pseudo–pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine

• COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant

• The Frailty Phenotype in Hemodialysis Patients and its Association with Biochemical Markers of Mineral Bone Disorder, Inflammation and Nutrition

• Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still’s disease. Does terminology matter?

• Non secretory myeloma in young man mimicking the Gorham disease: case report and the literature review

• Association between admission blood glucose and prognosis in non-diabetic patients with first-ever acute myocardial infarction

• Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome

• Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren syndrome

• Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment

• Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas

• Systematic Approach to Celiac Disease: A Comprehensive Review for Primary Providers

• The role of thyroid hormones in carotid arterial wall remodeling in women

• Serum Uric Acid as a Predictor of cardio-and cerebro-vascular diseases in Maintenance Hemodialysis Patients

• Anti - Dense Fıne Speckled (DFS) Antibody: its staınıng pattern in indirect immunofluorescence and its clinical relevance

• Cardiac biomarkers alterations in patients with SARS-CoV-2 infection

• Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience

• Autoimmune Polyglandular Syndrome Type II presenting as Subacute Combined Degeneration of Spinal Cord: A Neuroendocrinology Crossroad

• Erratum for the paper Erfani A. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2015;53(4):304-14.